Sinobiomed Inc., of Shanghai, China, named Anchie Kuo president and CEO...Brent Suen head of strategic development and mergers and acquisitions

MorphoSys AG, of Martinsried, Germany, appointed Ulrich Moebius head of preclinical development and project management...He also will provide strategic direction to Novacta's R&D team and will become chairman of the scientific advisory board...Pharminox Ltd., of Nottingham, UK, appointed Lee Arnold, Adrian Harris and Robert Jackson to its scientific advisory board

Anecova SA, of Geneva, named Barry W. Wilson, Patrick Aebischer and Jeffrey B. Jump to its board...ARCA biopharma Inc., of Broomfield, Colo., appointed Kathryn E. Falberg chief financial officer and chief operating officer...Gene Network Sciences Inc., of Cambridge, Mass., named Michael Gilman, founder and CEO of Stromedix Inc., to its board

New Leaf Venture Partners, of New York, named Srinivas Akkaraju managing director and to lead its West Coast biopharmaceuticals practice...OncoMethylome Sciences, of Liege, Belgium, named Gerard Vaillant to its board, and appointed Gert-Jan Renardel de Lavalette chief operating officer

Sander van Deventer, AMT's chief scientific officer and co-founder of the company, has been named interim CEO...Ligand Pharmaceuticals Inc., of San Diego, named Bruce A. Peacock and Steven J. Burakoff to its board...The company also added former FDA official Marianne Mann and former Merck & Co

The company also added former FDA official Marianne Mann and former Merck & Co...XOMA Ltd., of Berkeley, Calif., appointed Fred Kurland vice president of finance and chief financial officer

Clarus Ventures LLC, of Cambridge, Mass., promoted Emmett Cunningham to partner and Scott Requadt to transactional partner...Ensysce Biosciences Inc., of Houston, appointed Lynn Kirkpatrick president and CEO...ONI BioPharma Inc., of Alachua, Fla., named Martin Handfield director of research and development

and Steve Neben senior director of project and alliance management...Oxigene Inc., of Waltham, Mass., named Nicole Onetto and Eric K. Rowinsky to the board of its subsidiary Symphony ViDA Inc

TyRx Inc., of Monmouth Junction, N.J., appointed William G. Dempsey an independent director. Vitae Pharmaceuticals Inc., of Fort Washington, Pa., promoted Tina Fiumenero to chief financial officer. XOMA Ltd., of Berkeley, Calif., appointed Stephen K. Doberstein vice president of research.

Prognostix Inc., of Cleveland, appointed Jake Orville president and CEO...Thomas Hecht was appointed chairman, and Michael Motschmann will join the board...SuppreMol also named Fritz Melchers and Falk Nimmerjahn to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., appointed James J. O'Leary vice president and chief medical officer...Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

The company appointed Craig A. Collard president and CEO and named Alastair McEwan chairman...It also appointed Christopher Codeanne, Michael Enright and Michael Heffernan to the board

Bioheart Inc., of Sunrise, Fla., appointed Matt Fendrich vice president of sales and marketing and named Alan P. Timmins to the board...Biovail Corp., of Toronto, appointed H. Christian Fibiger senior vice president and chief scientific officer of Biovail Laboratories International SRL...BioXcel Corp., of New Haven, Conn., added R. Christopher Seaton, Martha Matteo and Kevin Rakin to its corporate advisory board

AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe...Adimab Inc., of Lebanon, N.H., appointed Guy Van Meter senior director and head of business development...Antisoma plc, of London, appointed Eric Dodd chief financial officer and board member

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Quinnova Pharmaceuticals Inc., of Newtown, Pa., appointed Christopher Hensby senior vice president of research and development...Seattle Genetics Inc., of Bothell, Wash., named Elaine Waller senior vice president of regulatory affairs and appointed Christopher Pawlowicz senior vice president of human resources...Somnus Therapeutics Inc., of Bedminster, N.J., appointed Gary Cupit, Linda C. Hogan, David Ramsay and Jack W. Britts to its board

It also named Chas Bountra as chairman and Annette Dolphin to its scientific advisory board...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Abeome Corp., of Athens, Ga., formed a scientific advisory board, led by Richard Meagher, with the appointments of Christine Debouck, Jeff Boyd and Linda Matsuuchi...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer